We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

5214:TSENippon Electric Glass Co., Ltd. Analysis

Data as of 2026-06-14 - not real-time

¥6,066.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Nippon Electric Glass is trading below its 20‑day (≈6,485) and 50‑day (≈6,910) simple moving averages, with an RSI around 41 and a bearish MACD histogram, suggesting short‑term technical weakness despite a neutral overall trend and rising volume. The stock’s beta of roughly 0.63 and a 30‑day volatility near 69% point to modest market sensitivity but heightened price swings, while support sits near 5,580 and resistance near 7,100.
Fundamentally, the company appears undervalued with a trailing PE of about 16 versus an industry average of 37 and a price‑to‑book below 1, offering a dividend yield of roughly 2.6% and a payout ratio under 40%, indicating sustainable income. Recent Q1 results show a notable rise in net profit to ¥8.3 bn on flat revenue, and the balance sheet is net‑cash positive despite a high debt‑to‑equity ratio, while analysts maintain a “buy” stance with a target price implying ~18% upside, all amid an “Extreme Greed” market sentiment.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below short‑term moving averages and bearish MACD
  • Attractive dividend yield and undervalued valuation multiples
  • Rising volume indicating potential accumulation

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervaluation relative to industry peers
  • Sustainable dividend and strong net‑cash position
  • Quarterly earnings improvement and positive analyst outlook

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Strategic exposure to growing specialty glass markets (display, semiconductor, automotive)
  • Consistent cash generation capacity and low beta
  • Long‑term dividend sustainability and potential for capital appreciation

Key Metrics & Analysis

Financial Health

Revenue Growth0.30%
Profit Margin10.57%
P/E Ratio15.9
ROE6.90%
ROA2.99%
Debt/Equity19.57
P/B Ratio0.9
Industry P/E36.8

Technical Analysis

TrendNeutral
RSI41.0
Support¥5,578.00
Resistance¥7,104.00
MA 20¥6,484.75
MA 50¥6,910.46
MA 200¥6,007.01
MACDBearish
VolumeIncreasing
Fear & Greed Index89.86

Valuation

Target Price¥7,188.33
Upside/Downside18.50%
GradeUndervalued
TypeBlend
Dividend Yield2.64%

Risk Assessment

Beta0.63
Volatility69.04%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.